trial · primary record
Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs
Pathogen Infection Covid-19 Infection
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Clinical improvement based on the 7-point scale |
| Registry ID | NCT04276896 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:39.954Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04276896
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.